Evidence map›Paper›PMID 24574340›Full record

ArticleScience translational medicine2014

A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism.

Anne L Robertson, Geoffrey R Holmes, Aleksandra N Bojarczuk, Joseph Burgon, Catherine A Loynes, Myriam Chimen, Amy K Sawtell, Bashar Hamza, Joseph Willson, Sarah R Walmsley and 11 more

Abstract read
In one paragraph

Article in Science translational medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 1 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 1 synthesis or guideline pooled it, 250 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Cystic fibrosis: insights from zebrafish models.Disease models & mechanisms · 2026
    Review
  6. Article
  7. Chemical and Mechanical Regulation of Leukocyte Migration.Cold Spring Harbor perspectives in biology · 2026
    Review
  8. Review
  9. Article
  10. Characterizing trajectories of innate immune cells in larval zebrafish.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Anne L RobertsonMedical Research Council Centre for Developmental and Biomedical Genetics, University of Sheffield, Sheffield S10 2TN, UK.
Geoffrey R Holmes
Aleksandra N Bojarczuk
Joseph Burgon
Catherine A Loynes
Myriam Chimen
Amy K Sawtell
Bashar Hamza
Joseph Willson
Sarah R Walmsley
Sean R Anderson
Mark C Coles
Stuart N Farrow
Roberto Solari
Simon Jones
Lynne R Prince
Daniel Irimia
G Ed Rainger
Visakan Kadirkamanathan
Moira K B Whyte
Stephen A Renshaw
University of Sheffield · GBMedical Research Council · GBMassachusetts General Hospital · USUniversity of Birmingham · GBUniversity of York · GBGlaxoSmithKline (United Kingdom) · GBImperial College London · GB

Funding

Bio-MicroElectroMechanical Systems Resource CenterP41EB002503 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET · 2004 to 2018
$17.4M
Neutrophil Decision Making in Confined Environments in Health and DiseaseR01GM092804 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI IRIMIA, DANIEL · 2010 to 2022
$4.3M
British Heart Foundation RG/12/7/29693Medical Research Council G0601156Medical Research Council G0700091Medical Research Council G0701932Medical Research Council G0802527Medical Research Council G108/595Medical Research Council MC_PC_12022Medical Research Council MR/K006312/1NIBIB NIH HHS P41 EB002503NIGMS NIH HHS R01 GM092804Wellcome TrustWellcome Trust 098516Wellcome Trust GR077544AIA
6 · The paper itself

Abstract

Diseases of failed inflammation resolution are common and largely incurable. Therapeutic induction of inflammation resolution is an attractive strategy to bring about healing without increasing susceptibility to infection. However, therapeutic targeting of inflammation resolution has been hampered by a lack of understanding of the underlying molecular controls. To address this drug development challenge, we developed an in vivo screen for proresolution therapeutics in a transgenic zebrafish model. Inflammation induced by sterile tissue injury was assessed for accelerated resolution in the presence of a library of known compounds. Of the molecules with proresolution activity, tanshinone IIA, derived from a Chinese medicinal herb, potently induced inflammation resolution in vivo both by induction of neutrophil apoptosis and by promoting reverse migration of neutrophils. Tanshinone IIA blocked proinflammatory signals in vivo, and its effects are conserved in human neutrophils, supporting a potential role in treating human inflammation and providing compelling evidence of the translational potential of this screening strategy.

Indexed as

High-Throughput Screening AssaysZebrafishAbietanesAnimalsAnimals, Genetically ModifiedAnti-Inflammatory AgentsApoptosisCell MovementCells, CulturedDisease Models, AnimalDose-Response Relationship, DrugDrug Evaluation, PreclinicalGreen Fluorescent ProteinsHumansInflammationLarvaAbietanesAnti-Inflammatory AgentsGreen Fluorescent Proteinstanshinone

Identifiers

PMID24574340
PMCPMC4247228
OpenAlexW2152961129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.